Author: Dande, Ranadheer; Qureshi, Anum; Persaud, Kia; Puri, Chahat; Zulfiqar, Sajida; Awasthi, Shankar
Title: Remdesivir in a pregnant patient with COVID-19 pneumonia Cord-id: mtiqsz79 Document date: 2021_1_26
ID: mtiqsz79
Snippet: Remdesivir is an antiviral drug currently being studied as a potential treatment of pneumonia caused by infection with SARS-CoV-2. The Adaptive Covid-19 Treatment Trial (ACTT-1) by NIH and the SIMPLE study by Gilead Sciences are two major trials that showed promising results of Remdesivir in the non-pregnant population. We are presenting the case of a pregnant patient who was diagnosed with COVID-19 pneumonia and successfully treated with Remdesivir.
Document: Remdesivir is an antiviral drug currently being studied as a potential treatment of pneumonia caused by infection with SARS-CoV-2. The Adaptive Covid-19 Treatment Trial (ACTT-1) by NIH and the SIMPLE study by Gilead Sciences are two major trials that showed promising results of Remdesivir in the non-pregnant population. We are presenting the case of a pregnant patient who was diagnosed with COVID-19 pneumonia and successfully treated with Remdesivir.
Search related documents:
Co phrase search for related documents- active infection and admission time: 1, 2
- active infection and lymphocyte count: 1, 2, 3
- admission time and lung opacity: 1, 2
- admission time and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57
- lung opacity and lymphocyte count: 1, 2, 3, 4, 5, 6, 7
Co phrase search for related documents, hyperlinks ordered by date